Outcome of Hydroxyurea Use in SCD and Evaluation of Patients’ Perception and Experience in Nigeria

Outcome of Hydroxyurea Use in SCD and Evaluation of Patients’ Perception and Experience in Nigeria

Introduction: Hydroxyurea (HU) has been shown to be beneficial in the management of sickle cell disease (SCD) as it improves treatment outcomes. However, despite the benefits of HU, its uptake among SCD patients in Nigeria remains low.Objective: This study aimed to assess the perception and experien...

Full description

Bibliographic Details
Main Authors: Reuben Ikechukwu Chianumba, Akinyemi O. D. Ofakunrin, Jack Morrice, Olaniyi Olanrewaju, Oluseyi Oniyangi, Aisha Kuliya-Gwarzo, Uche Nnebe-Agumadu, Hezekiah Alkali Isa, Obiageli Eunice Nnodu
Format: Article
Language:English
Published: Frontiers Media S.A. 2022-03-01
Series:Frontiers in Genetics
Subjects:
sickle cell disease
patients perception
patients experience
Nigeria
hydroxyurea
Online Access:https://www.frontiersin.org/articles/10.3389/fgene.2022.826132/full

Internet

https://www.frontiersin.org/articles/10.3389/fgene.2022.826132/full

Similar Items